Genmab — April 2019
-
GEN1046 Safety Trial in Patients With Malignant Solid Tumors https://clinicaltrials.gov/ct2/show/NCT03917381?term=daratumumab+OR+ofatumumab+OR+tisotumab+OR+Genmab+OR+arzerra+OR+duobody&lupd_s=04%2F15%2F2019&rank=8
-
E.L. Tusinde tak for link.
-
naaaa...ved en Maia rejection, så vil kursen nok suse et par hundrede points ned, så tror jeg ikke man kan udlede, at der ikke er mange, som tror det. Biotek-/pharma har det svært med at tiltrække købere i disse dage, og ingen nye tilkøb i DK foran 3 markedsdage lukket - men øv er det da.
-
Danske aktier kan bare ikke følge med udlandet. USA og nu også Tyskland har jo haft en glimrende uge, hvorimod Danmark overhovedet ikke er kommer ud af startfeltet!
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind